We use cookies to give you the best possible experience on our website.

Case Studies

 

The Innovation Case Studies section provides a comprehensive list of exemplar innovation projects from across the NHS. These innovations have been carefully selected to represent a range of ideas from medical technologies through to service and pathway re design. Each case study provides a background to the innovation and a contact for further information.

 Click on the Case Study Browse area on the right to find examples by clinical area.

If you have an innovation case study you would like us to publish on the portal please contact the Innovation team at england.innovation@nhs.net

Small arrow Latest Case Studies

Content with Clinical areas Diagnostics & Imaging .

There are no results.
Small arrow All Case Studies (A to Z)

Content with Clinical areas Diagnostics & Imaging .

Ambulatory ECG Monitor

The C.Net5000 ambulatory ECG monitor provides 24 or 48 hour ‘Holter’ ECG arrhythmia analysis quickly and efficiently in Primary Care. This is a ‘Holter’ monitor with built-in...

Genomic Clinical Work-bench (GCW)

GCW is an innovation that will transform access to, and the effectiveness of, genomic tests, thereby directly improving the care of hundreds of thousands of NHS patients whilst offering...

Genomic Profiling at Diagnosis of Acute Myeloid Leukaemia (AML)

This is a strategy to streamline genetic testing at diagnosis of acute myeloid leukaemia. There is a need for change in laboratory testing for AML and it is anticipated that...

Molecular Diagnostic Test for Childhood Liver Disease

Childhood liver disease due to rare inherited metabolic disorders is a clinically important condition requiring accurate diagnosis to enable early intervention and treatment. ...

Next Generation Sequencing (NGS)

The majority of conditions screened for in Newborn Screening (NBS) are genetic and rare but have to be amenable to detection by existing methodologies. NGS could potentially...

Next Generation Sequencing (NGS) – Missing heritability within non-coding genomic regions

Approximately 5-10% of all cancers are considered to be hereditary, caused by an alteration within a single gene. It is important to identify the underlying genetic aberration...

Next Generation Sequencing (NGS) – Multi-gene panels for inherited cancer

Approximately 5-10% of all cancers are considered to be hereditary. Individuals with a gene mutation have up to a 100% risk of developing cancer. Detection of gene mutations...

Next Generation Sequencing (NGS) – Sudden Cardiac Death

The causes of sudden cardiac death (SCD) are diverse and, in the absence of coronary artery disease, difficult to investigate, especially if genetic. Accurate identification...

NHS Copy Number Variation (CNV) Consortium Database

The detection by microarray of copy number variation (CNV) associated with developmental disorders, is becoming increasingly widespread in the UK and has been recommended as the frontline...

Targeted Gene Panels

A number of cancer drug therapies are available that can be administered to patients in a targeted manner based on the individual genetic profile of tumour sample. These drugs...